25 May 2013
Keywords: dor, gets, 5m, sigma, under, orbec, deal
Article | 08 December 2008
USA-based DOR BioPharma has received $1.5 million from Sigma-Tau Pharmaceuticals as part of an agreement allowing the latter to negotiate
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 December 2008
24 May 2013
© 2013 thepharmaletter.com